The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy

International Journal of Gynecological Cancer

Volumn 22, Issue 6, 2012, Pages 1037-1043

  Fu, Chun ^a   Bian, Dujun ^a   Liu, Fengying ^a   Feng, Xiaoyan ^a   Du, Wanping ^a   Wang, Xiangquan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Diffusion weighted magnetic resonance imaging; Locally advanced cervical cancer; Neoadjuvant chemotherapy; Sagittal and axial planes imaging

Indexed keywords

CISPLATIN; DOCETAXEL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMOSENSITIVITY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; LOCALLY ADVANCED CERVICAL CANCER; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPHADENECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; CARCINOMA, SQUAMOUS CELL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84863609329     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31825736d7     Document Type: Article

References (21)

1. Ying X, Liang LZ, Cao LP, et al. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Gynecol Oncol. 2011;123:99-104.
2. Kumar JV, Doval DC, Rao R, et al. A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery. Int J Gynecol Cancer. 2009;19:417-422.
3. Kilickesmez O, Bayramoglu S, Inci E, et al. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones. Acta Radiol. 2009;50:340-347.
4. Levy A, Medjhoul A, Caramella C, et al. Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review. J Magn Reson Imaging. 2011;33:1020-1027.
5. Liu Y, Bai R, Sun H, et al. Diffusion-weighted magnetic resonance imaging of uterine cervical cancer. J Comput Assist Tomogr. 2009;33:858-862.
6. Xue HD, Li S, Sun F, et al. Clinical application of body diffusion weighted MR imaging in the diagnosis and preoperative N staging of cervical cancer. Chin Med Sci J. 2008;23:133-137.
7. Liu Y, Bai R, Sun H, et al. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin Radiol. 2009;64:1067-1074.
8. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol. 2003;45:169-184.
9. Nishino M, Jagannathan JP, Ramaiya NH, et al. Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know. Am J Roentgenol. 2010;195:281-289.
10. Punwani S. Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications. Eur J Radiol. 2011;78:21-29.
11. Chen J, Zhang Y, Liang B, et al. The utility of diffusion-weighted MRimaging in cervical cancer. Eur J Radiol. 2010;74e:101-106.
12. Kharuzhyk SA, Petrovskaya NA, Vosmitel MA. Diffusion-weighted magnetic resonance imaging in non-invasive monitoring of antiangiogenic therapy in experimental tumor model. Exp Oncol. 2010;32:104-106.
13. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol. 2007;188:1622-1635.
14. Naganawa S, Sato C, Kumada H, et al. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol. 2005;15:71-78.
15. Zhang Y, Liang BL, Gao L, et al. Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma. Ai Zheng. 2007;26:508-512.
16. Rizzo S, Summers P, Raimondi S, et al. Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy. Radiol Med. 2011;116:766-780.
17. Harry VN, Semple SI, Gilbert FJ, et al. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol. 2008;111:213-220.
18. Hori M, Kim T, Murakami T, et al. Uterine cervical carcinoma: preoperative staging with 3.0-T MR imagingVcomparison with 1.5-T MR imaging. Radiology. 2009;251:96-104.
19. Lin YC, Lin G, Chen YR, et al. Role of magnetic resonance imaging and apparent diffusion coefficient at 3T in distinguishing between adenocarcinoma of the uterine cervix and endometrium. Chang Gung Med J. 2011;34:93-100.
20. Yu SP, He L, Liu B, et al. Differential diagnosis of metastasis from non-metastatic lymph nodes in cervical cancers: pilot study of diffusion weighted imaging with background suppression at 3T magnetic resonance. Chin Med J. 2010;123:2820-2824.
21. Ho KC, Lin G, Wang JJ, et al. Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. Eur J Nucl Med Mol Imaging. 2009;36:200-208.